HIV-1 entry inhibition capabilities of Isoflavones
Introduction: Over the years, HIV has persisted as a global health challenge. Although there is availability of anti-retroviral therapy, a cure remains elusive and the development of drug resistance to current drugs necessitates the development of novel therapies. This study investigated novel isofl...
Saved in:
| Main Authors: | Mr Steven Raubenheimer, Miss Phaladi Kunyane, Dr Mamoalosi Selepe, Dr Ntombenhle Gama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | International Journal of Infectious Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971224006921 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The synthesis and evaluation of 3-benzoylbenzofurans and their pyrazole derivatives against HIV-1 infections and cancer
by: Ms Sinothile Khuzwayo, et al.
Published: (2025-03-01) -
HIV-associated immune dysregulation in the placenta
by: Mrs Dalitso Kalua-Mwamlima, et al.
Published: (2025-03-01) -
Daidzein-rich isoflavone aglycones inhibit 17β-hydroxysteroid dehydrogenase 1 and increase estrogen sulfotransferase in endometriosis
by: Yosuke Tarumi, et al.
Published: (2025-12-01) -
Role of isoflavones in multiple sclerosis
by: V. Anushya vardhini, et al.
Published: (2025-12-01) -
Oestrogene mimetic isoflavones’ pharmacokinetics and pharmacodynamics
by: Anca Dragomirescu,, et al.
Published: (2008-12-01)